A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
The current price of AstraZeneca PLC in the market is $95.43, with a 24-hour trading volume of $588.49M. The asset's market cap is $295.88B, after moving 0.68% in the last day.
Tokenized AstraZeneca PLC is trading at $94.91, with a tokenized market cap of $711.89K and a 24-hour trading volume of $67.14K. The tokenized asset has moved -0.28% in the past 24 hours.